Sales of Companion Animal Specialty Drugs in North America to Remain High over 2027

Rapid urbanisation and commonness of isolated family units in the modern world are two of the major reasons that have led to increasing humanization of animals. The trend of pet adoption as companions has been rising all over the world, fueling the demand for veterinary products. A recent study conducted by Future Market Insights (FMI) reveals that revenues from the worldwide sales of companion animal specialty drugs are expected to reach US$ 29,151.5 Mn by 2017-end. The global companion animal specialty drugs market is expected to witness a CAGR of 4.9% in terms of revenue between 2017 and 2027.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-3984

FMI’s report titled “Companion Animal Specialty Drugs Market: Global Industry Analysis and Opportunity Assessment 2017-2027” also projects that sales of animal specialty drugs will remain high in regions such as North America, Western Europe and Asia Pacific excluding Japan (APEJ) during the forecast period. In 2016, North America accounted for around 33% revenue share of the market mainly due to the adoption of innovative service delivery models by most retailers in the region. In addition, the companion animal specialty drugs market in North America will continue to be highly lucrative over 2027.

Towards the end of assessment period, parasiticides animal specialty drug is estimated to garner US$ 17,750.7 Mn in revenues. Among all the product types, demand for parasiticides will continue to gain the highest traction over the next couple of years. Moreover, expansion of distribution networks, especially in emerging countries is anticipated to further boost the sales of such companion animal specialty drugs. Manufacturers are also laying greater emphases on product and process innovation in order to improve their product portfolio as well as to offer better drug options. The market is dominated by top four players, Elanco, Merial, Zoetis, Inc. and Bayer AG, which collectively account for nearly two-third of the market share in terms of revenue. Merck and Co., Inc, Boehringer Ingelheim GmbH, and Ceva Santé Animale are among other key players that have a healthy presence in the global companion animal specialty drugs market.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-3984

Key Highlights of the Report Include:

Rising cases of pet obesity fueling the demand for medicines. Pet obesity has become quite prevalent, owing to the rising tendency to overfeed pets. Extensive feeding can make a negative impact on the health of pets, therefore making them susceptible to more diseases.

Of late, higher importance to animal health and welfare has been observed in developing countries. This, in turn, is positively influencing the demand for compounded medication. Also, the need for easy access to services and affordable veterinary drugs is a major factor that is increasing the popularity of compounded drugs across the globe.

The arrival of new technologies, especially in biologics such as recombinant DNA vaccines for dogs are expected to eventually drive demand for specialties in veterinary medicines in 2017 and beyond.

Get access to full summary @: https://www.futuremarketinsights.com/reports/companion-animal-speciality-drugs-market

On the basis of distribution channels, veterinary clinics account for more than one-third of the market share. Around US$ 12,446.3 Mn worth companion animal specialty drugs are expected to be distributed through veterinary clinics in 2017.

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web:https://www.futuremarketinsights.com/

This release was published on openPR.